400-920-2911 sales@csnpharm.cn
CaSR
货号 | 产品名 | CAS号 | 信息 |
---|---|---|---|
CSN26427 | Tecalcet HCl | 177172-49-5 | Tecalcet Hydrochloride, an orally active calcimimetic compound, allosterically and positively modulates the calcium-sensing receptor (CaSR). Tecalcet Hydrochloride increases the sensitivity to activation by extracellular Ca2+. |
CSN11988 | Strontium Ranelate | 135459-87-9 | Strontium ranelate stimulates the calcium sensing receptors (CaSR) and leads to the differentiation of pre-osteoblast to osteoblast which increases the bone formation. |
CSN22916 | Gadolinium Trichloride | 10138-52-0 | Stretch-activated calcium channel blocker; calcium-sensing receptor agonist |
CSN11585 | NPS-2143 | 284035-33-2 | NPS-2143 is a selective potent calcium ion-sensing receptor antagonist with IC50 of 43 and 41 nM for cytoplasmic Ca2+ concentrations and parathyroid hormone secretion, respectively. |
CSN18211 | NPS-2143 HCl | 324523-20-8 | NPS-2143 HCl is a potent and selective calcium ion-sensing receptor antagonist with IC50 of 43 and 41 nM for cytoplasmic Ca2+ concentrations and parathyroid hormone secretion, respectively. |
CSN26428 | Ligustroflavone(Nuezhenoside) | 260413-62-5 | Ligustroflavone, extracted from Ligustrum lucidum, is a potential candidate as calcium-sensing receptor (CaSR) antagonist. Ligustroflavone exhibits protective effects against diabetic osteoporosis in mice[1]. |
CSN12305 | Cinacalcet | 226256-56-0 | Cinacalcet is an orally active, second-generation calcimimetic compound and represents a class of compounds for the treatment of hyperparathyroidism. |
CSN12758 | Cinacalcet HCl | 364782-34-3 | Cinacalcet HCl is an orally active calcimimetic compound and represents a class of compounds for the treatment of hyperparathyroidism. |